What’s Next For Nevro Stock After A 22% Fall In A Month?

What’s Next For Nevro Stock After A 22% Fall In A Month?

The stock price of Nevro, a medical devices company, has seen a large 22% fall in a month. This can largely be attributed to the outcome of a lawsuit against Nevro for patent infringement, with the jury siding with Boston Scientific and finding Nevro to have infringed two of Boston Scientific’s…